Benjamin J. Hindson - Nov 22, 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
President and Chief Scientific Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson
Stock symbol
TXG
Transactions as of
Nov 22, 2022
Transactions value $
-$80,434
Form type
4
Date filed
11/23/2022, 04:02 PM
Previous filing
Sep 16, 2022
Next filing
Dec 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale -$12.2K -359 -0.16% $34.07 220K Nov 22, 2022 Direct F1
transaction TXG Class A Common Stock Sale -$31.2K -915 -0.42% $34.07 219K Nov 22, 2022 Direct F1
transaction TXG Class A Common Stock Sale -$37K -1.09K -0.5% $34.07 218K Nov 22, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

President and Chief Scientific Officer